Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

MIRALUMA DIN 02327929

Status: Cancelled Pre Market
Holder: LANTHEUS MI CANADA INC
Molecule: TETRAKIS [CU(MIBI)4]BF4

Health Canada record

Active ingredient(s)TETRAKIS [CU(MIBI)4]BF4 1 MG
Dosage formPowder For Solution
RouteIntravenous
ScheduleSCHEDULE C
ClassRadiopharmaceutical
ATC
Original market date
Current status date15-Mar-2017
SourceHealth Canada DPD

Establishment licence of the holder

Lantheus MI Canada Inc — licence 101647, currently licensed, last inspection rating C (2023-05-03).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing TETRAKIS [CU(MIBI)4]BF4

DINProductCompanyFormStrengthStatus
02328003CARDIOLITELANTHEUS MI CANADA INCPowder For SolutionTETRAKIS [CU(MIBI)4]BF4 1 MGMarketed
02327732DRAXIMAGE SESTAMIBIJUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMAPowder For SolutionTETRAKIS [CU(MIBI)4]BF4 1 MGMarketed
02329794KIT FOR THE PREPARATION OF TECHNETIUM TC 99M SESTAMIBI INJECTIONCURIUM CANADA INCKit; Powder For SolutionTETRAKIS [CU(MIBI)4]BF4 1 MGMarketed
Request a quote for MIRALUMA

How to read a Canadian DIN record